The rise of gene editing forces regulators to confront a difficult question: How to protect fair play in the age of genomic medicine.
New York Stem Cell Foundation Collaborative (JAX-NYSCF) today announced a five-year strategic research collaboration with GSK focused on advancing human cellular models of neurodegenerative disease, ...
Century Therapeutics (IPSC) aims at a durable “once-and-done” Type 1 diabetes cure with hypoimmune iPSC beta cells; runway to ...
Even in the best-case scenario, when fertility clinics transfer chromosomally normal embryos into a would-be mother's uterus, ...
3hon MSN
A bacterium's built-in compass, explained: Single-cell magnetometry confirms Earth-field alignment
Some bacterial species possess an astonishing ability: They use Earth's magnetic field to orient themselves. To better understand this mechanism, the team led by Argovia-Professor Martino Poggio from ...
A newly identified lung cell “switch” could help doctors unlock the lungs’ natural ability to heal themselves.
6hon MSN
Renewable biological catalyst carries the potential to transform wastewater into phosphorus resource
Phosphorus is an essential nutrient for plants and managing its availability is critical for growing crops to maintain the global food supply. In an effort to move toward a more sustainable bioeconomy ...
Imagine a "smart fluid" whose internal structure can be rearranged just by changing temperature. In a new study published in Matter, researchers report a way to overcome a long-standing limitation in ...
Breast cancer (BC) is the most common cancer and the second leading cause of cancer death in women. It is a highly variable disease, defined as a malignancy of the epithelial ducts in breast tissue.
Based on breakthrough findings from Dr. Adams' lab uncovering a novel druggable cellular detoxification pathway driving Cisplatin resistance in NSCLC, this collaboration aims to design novel ...
Previous laboratory research has shown that ivermectin could have anticancer effects because it promotes cell death and inhibits the growth of tumor cells. "It actually has been studied both with NIH ...
News-Medical.Net on MSN
New strategy harnesses pre-existing antiviral immunity to boost anti-tumor responses
Because many different types of cancer cells overexpress programmed death-ligand 1 (PD-L1), this cell surface protein is a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results